Metabolism and excretion of canagliflozin in mice, rats, dogs, and humans.
about
Canagliflozin Treatment in Patients with Type 2 Diabetes MellitusSGLT2 inhibitors act from the extracellular surface of the cell membraneEffects of rifampin, cyclosporine A, and probenecid on the pharmacokinetic profile of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants.Canagliflozin: a review of its use in patients with type 2 diabetes mellitus.Clinical Pharmacokinetic, Pharmacodynamic, and Drug-Drug Interaction Profile of Canagliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor.Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus.Characterization of forced degradation products of canagliflozine by liquid chromatography/quadrupole time-of-flight tandem mass spectrometry and in silico toxicity predictions.Syntheses of isotope-labeled SGLT2 inhibitor canagliflozin (JNJ-28431754).Biotransformation and mass balance of the SGLT2 inhibitor empagliflozin in healthy volunteers.In vitro and physiologically-based pharmacokinetic based assessment of drug-drug interaction potential of canagliflozin.Difference in the Pharmacokinetics and Hepatic Metabolism of Antidiabetic Drugs in Zucker Diabetic Fatty and Sprague-Dawley Rats.
P2860
Q26777529-14A9D1EB-8A2E-46C0-BC63-8BBF586CF6C8Q34400029-3B192468-4256-4FE2-8483-652EED0A85DDQ36022710-62B74360-B8BC-46A0-9CA2-84F257549C43Q38212007-B00150E7-FFCF-4CBF-8551-DC531B10FA3EQ38515085-6D790AF3-C5D2-45CE-8BE2-1EFD0DF8D0C1Q38573559-824613BD-9197-46CE-B19E-92C5CC298CA3Q47798294-1C220C4A-6109-464D-A458-15ACAE8236F4Q47916522-F513AE64-6297-4985-B755-A2FAE5DEB5E8Q50454359-FC2A91E7-2D54-4B83-95EA-657F07A65248Q51060483-D8B696D6-5A03-4A40-BAE9-4B0A51DA07DBQ53784315-CF6B8651-1C93-4888-9789-6E001F57C73F
P2860
Metabolism and excretion of canagliflozin in mice, rats, dogs, and humans.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Metabolism and excretion of canagliflozin in mice, rats, dogs, and humans.
@ast
Metabolism and excretion of canagliflozin in mice, rats, dogs, and humans.
@en
type
label
Metabolism and excretion of canagliflozin in mice, rats, dogs, and humans.
@ast
Metabolism and excretion of canagliflozin in mice, rats, dogs, and humans.
@en
prefLabel
Metabolism and excretion of canagliflozin in mice, rats, dogs, and humans.
@ast
Metabolism and excretion of canagliflozin in mice, rats, dogs, and humans.
@en
P2093
P356
P1476
Metabolism and excretion of canagliflozin in mice, rats, dogs, and humans
@en
P2093
Damayanthi Devineni
David C Evans
Dennis Kalamaridis
Ellen Scheers
Heng Keang Lim
Jose Silva
Mark D Johnson
Michael F Kelley
Rao N V S Mamidi
P304
P356
10.1124/DMD.113.056440
P577
2014-02-25T00:00:00Z